Jonathan M Glenn, Chief Executive Officer at Consort Medical, holds 40.60M shares in Tissue Regenix (Ticker: GB:TRX), holds 395.42K shares in Consort Medical (Ticker: GB:CSRT). Most recently, Jonathan M Glenn Bought ― shares of Tissue Regenix on Jun 05, 2020 for an estimated value of 100.00K.
What is the percentage of profitable transactions made by Jonathan M Glenn?
The percentage of profitable transactions made by Jonathan M Glenn is 31%.
What is the average return per transaction made by Jonathan M Glenn?
The average return per transaction made by Jonathan M Glenn is -5.50%.
What stocks does Jonathan M Glenn hold?
Jonathan M Glenn holds: GB:CSRT, GB:TRX stocks.
What was Jonathan M Glenn’s latest transaction?
Jonathan M Glenn latest transaction was an Informative Buy of 100.00K.
What was Jonathan M Glenn's most profitable transaction?
Jonathan M Glenn’s most profitable transaction was an Informative Sell of GB:CSRT stock on August 23, 2018. The return on the trade was 30.80%.
What is Jonathan M Glenn's role in Consort Medical?
Jonathan M Glenn's role in Consort Medical is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.